During the past decade, Universitatsklinik Essen, Klinik und Poliklinik fur Neurologie conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universitatsklinik Essen, Klinik und Poliklinik fur Neurologie" #1 collaborator was "Chugai Pharmaceutical" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Universitatsklinik Essen, Klinik und Poliklinik fur Neurologie" are "Brain Ischemia" (1 trials), "Cerebrovascular Disorders" (1 trials), "Epilepsy" (1 trials), "Generalized Myasthenia Gravis" (1 trials) and "Multiple Sclerosis, Relapsing-Remitting" (1 trials). Many other conditions were trialed in "Universitatsklinik Essen, Klinik und Poliklinik fur Neurologie" in a lesser frequency.

Most popular intervention types in "Universitatsklinik Essen, Klinik und Poliklinik fur Neurologie" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "DP-b99" (1 trials), "Ocrelizumab" (1 trials), "Placebo" (1 trials), "Satralizumab" (1 trials) and "Zonegran" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universitatsklinik Essen, Klinik und Poliklinik fur Neurologie" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Universitatsklinik Essen, Klinik und Poliklinik fur Neurologie". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Universitatsklinik Essen, Klinik und Poliklinik fur Neurologie, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Universitatsklinik Essen, Klinik und Poliklinik fur Neurologie, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".